Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are statins anti-inflammatory?

Gavin J Blake1, Paul M Ridker

  • 1Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. pridker@partners.org

Current Controlled Trials in Cardiovascular Medicine
|November 21, 2001
PubMed
Summary

Statin therapy significantly reduces cardiovascular events, potentially beyond lipid lowering alone. Anti-inflammatory effects of statins may enhance clinical benefits, with inflammation markers helping identify optimal patient candidates.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Administration of EAPCI patient video animation versus standard patient information leaflets in the catheterization laboratory: Impact on patient experience assessed using the PATCATH questionnaire.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Drug Coated Balloons Versus Drug-Eluting Stents in Patients With De Novo Coronary Artery Disease.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2025
Same author

Microcosting analysis of percutaneous coronary intervention with and without intracoronary imaging in an Irish tertiary referral centre.

Open heart·2025
Same author

Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study.

Circulation·2025
Same author

Impact on percutaneous coronary intervention for acute coronary syndromes during the COVID-19 outbreak in a non-overwhelmed European healthcare system: COVID-19 ACS-PCI experience in Ireland.

BMJ open·2021
Same author

MiR-93-5p is a novel predictor of coronary in-stent restenosis.

Heart Asia·2019

Area of Science:

  • Cardiology
  • Pharmacology
  • Inflammation Research

Background:

  • Large clinical trials confirm statin therapy's efficacy in reducing cardiovascular events.
  • The observed benefits of statins may exceed those predicted by lipid-lowering effects alone.
  • Emerging evidence suggests statins possess anti-inflammatory properties contributing to clinical outcomes.

Purpose of the Study:

  • To explore the potential anti-inflammatory mechanisms of statin therapy.
  • To investigate whether inflammation markers can predict patient response to statins.
  • To enhance the understanding of statins' pleiotropic effects beyond lipid modification.

Main Methods:

  • Review of large-scale clinical trial data on statin therapy.
  • Analysis of basic science studies investigating statin mechanisms.

Related Experiment Videos

  • Evaluation of inflammatory markers, such as high-sensitivity C-reactive protein, alongside lipid parameters.

    • Main Results:

    • Statin therapy demonstrates significant reductions in cardiovascular event rates.
    • Evidence suggests statins exert anti-inflammatory effects contributing to clinical efficacy.
    • Inflammation markers may provide additional predictive value for statin response.

    Conclusions:

    • Statin therapy offers cardiovascular benefits potentially mediated by both lipid-lowering and anti-inflammatory actions.
    • Measuring inflammation markers like high-sensitivity C-reactive protein could refine patient selection for statin therapy.
    • Further research into statins' anti-inflammatory properties may optimize their clinical application.